Syapse Announces $35 Million Growth Investment With Innovatus Capital Partners To Expand Delivery Of Real-World Evidence Through Syapse’s Learning Health Network
Syapse Announces $35 Million Growth Investment With Innovatus Capital Partners To Expand Delivery Of Real-World Evidence Through Syapse’s Learning Health Network
07/27/22, 1:03 PM
Location
palo altoMoney raised
$35 million
Industry
life science
biotechnology
health care
Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $35 million growth funding transaction to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. The investment is led by an affiliate of Innovatus Capital Partners, LLC (Innovatus), with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital.
Company Info
Company
Syapse Holdings
Location
101 university avenue
palo alto, california, united states
Additional Info
Syapse Holdings Inc. is a pioneer in precision medicine solutions for community cancer centers. Its extensive network of community-based health systems, with more than 1,000 oncologists, its data and technology stack, and its dedicated team have been integrated into N-Power Medicine. Syapse’s existing offerings for its health system and pharma partners will be expanded with N-Power’s AI-enabled ‘human-in-the-loop’ approach to significantly expand access to prospective clinical trials and life-saving innovations for patients in community settings.